|
Hemeroteca 
|
HIV Vaccine Trial Results An Opening for Further Research February 4, 2010 By Raphael Dolin, M.D. HIV-AIDS has emerged as an enormous, worldwide public health problem over the past 25 years. An estimated 33 million persons are infected with human immunodeficiency virus type 1 (HIV-1), and more than 7000 new infections occur every day.1 Although major advances have been made in the treatment of HIV-1 infection and in certain behavioral approaches to the prevention of HIV infection, ultimately, control will most likely depend on the development and application of a safe and effective HIV vaccine. Substantial effort is being expended to develop an HIV vaccine through a variety of approaches.2 However, disappointing results have emerged from . . Para ver el artículo complete dé click en el siguiente enlace: http://content.nejm.org/cgi/content/full/361/23/2279 Fuente: The New England Journal of Medicine. 
|